GlassScriptPhysician profile
Kerry T Thibodeaux
NPI 1093774192
$83,766.84
in general payments reported to CMS, 2019-2025
16 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $6,723 · 2021: $19K · 2022: $3,571 · 2023: $1,910 · 2024: $461 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,476 · Consulting Fee: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,475.57 |
| Consulting Fee | $1,350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $47,774.03 | 2019-2025 | Puraply Wound Matrix, Puraply, Puraply Am |
| Kci USA, INC. | $33,683.20 | 2019-2023 | 3m Cavilon, Promogran Prisma, Activ.A.C. |
| Aroa Biosurgery Incorporated | $1,074.91 | 2023-2024 | |
| Kerecis Limited | $280.12 | 2021-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Ets Wound Care LLC | $275.12 | 2023-2024 | Mirragen Advanced Wound Matrix |
| Hartmann USA, INC. | $122.30 | 2022-2025 | Zetuvit Plus, Coactive Plus, Zetuvit Plus 10x10 P10 |
| Wound Management Technologies, INC | $98.63 | 2019 | |
| Smith+Nephew, INC. | $90.14 | 2019-2023 | Iodosorb Ointment 40g USA, Regranex, Collagenase Santyl |
| Advanced Oxygen Therapy INC. | $83.57 | 2023 | Topical Oxygen Chamber For Extremities |
| Reprise Biomedical, INC. | $74.52 | 2024-2025 | Miro3d, Miro 3d |
| Inari Medical, INC. | $65.16 | 2020 | |
| Abbvie INC. | $62.37 | 2022-2025 | Dalvance |
| Acera Surgical, INC. | $51.83 | 2022 | |
| Convatec INC. | $17.97 | 2024 | |
| Allergan, INC. | $12.97 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Thibodeaux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.